Recent Articles

• 
  Pharmaceutical R&D

  Celltrion Near Breakthrough in Obesity, ADC Drugs

  View of Celltrion headquarters. Provided by Celltrion Celltrion is set to successively disclose research results for next-generation obesity treatments and antibody-drug conjugate (ADC) new drug candidates. Starting with the announcement of non-clinical results for its obesity treatment at the end o

  2026.07.29
• 
  DTx / Platform

  Persona AI Wins KRW 2.6 Billion AX Voucher to Automate Cell Therapy CMC

  (From left) Logos of Persona AI, CHA Biotech, Naver Cloud, and MediPlus Hyperautomation company Persona AI has been selected for the Ministry of Science and ICT’s “AX (AI Transformation) One-Stop Voucher” support program and will launch the development of an AI agent-based platform that automates re

  2026.07.29
• 
  Biopharma

  GrainOn Patents Capsule Withstands Strong Acidity

  Grain On Ancient Grains Materialization Research Institute. Provided by Grain On The center of gravity in the domestic health functional food and enzyme market is shifting from simple raw material content and marketing competition to “technologies that control in vivo absorption rates and safety of

  2026.07.29
• 
  Clinical Trial

  GC Green Cross to Run Phase 2 COVID Vaccine Trial After Government Backing

  GC Green Cross headquarters. Provided by GC Green Cross. GC Green Cross announced on the 27th that it has been selected as the company to carry out a phase 2 clinical trial project under the “mRNA Vaccine Development Support Project for Pandemic Preparedness,” overseen by the Korea Disease Control a

  2026.07.27
• 
  Clinical Trial

  HK inno.N K-CAB Expanded as GI Protector for Long-Term Painkiller Users

  HK Inno.N’s gastroesophageal reflux disease new drug K‑CAB series. Provided by HK Inno.N HK Inno.N announced on the 27th that its new drug K-CAB tablet (ingredient name: tegoprazan) for gastroesophageal reflux disease has received new approval for the indication of prevention of peptic ulcers associ

  2026.07.27
• 
  Investment

  Sound Vaccine Secures Hana Bank Investment, Speeds Global Trials

  디지털 hearing loss-related healthcare bio-venture Sound Vaccine announced that it has attracted strategic investment from Hana Bank based on its proprietary Threshold Sound Conditioning (TSC) technology.At the core of Sound Vaccine’s business, TSC is a customized auditory stimulation technology that l

  2026.07.24
• 
  Global Business

  Dong-A Socio to Reabsorb Dong-A Pharm, Become Holding Company

  Exterior view of Dong-A Socio Holdings and Dong-A Pharmaceutical. Provided by Dong-A Socio Holdings Dong-A Socio Holdings will reabsorb Dong-A Pharmaceutical, which was carved out through a physical split during its transition to a holding company structure in 2013, after 13 years. The move is inten

  2026.07.23
• 
  Biopharma

  Samsung Biologics Q2 operating profit KRW 586.4 billion, up 23%

  Panoramic view of Samsung Biologics headquarters. Courtesy of Samsung Biologics Samsung Biologics continued its solid growth momentum, supported by stable business operations and favorable foreign exchange effects.Samsung Biologics announced on the 23rd that it posted sales of KRW 1,320.9 billion an

  2026.07.23
• 
  Medical / Research

  “Is Stomach Ulcer a Man’s Disease?” Women Over 80 at Higher Risk

  Peptic ulcer disease is a condition in which the mucosa of the stomach or duodenum is damaged and wounds form. In severe cases, it can lead to serious complications such as bleeding or perforation. Getty Images Bank There is a perception that “stomach ulcers are a man’s disease,” but this can change

  2026.07.22
• 
  MedTech

  KRICT Develops Near-Infrared Phosphor for Long Surgeries

  From right, KRICT’s Nam Sang-hwan principal researcher, Park Young-il principal researcher, and researcher Choi Min-seok. Provided by KRICT Korea Research Institute of Chemical Technology (KRICT) announced on the 21st that it has developed a next-generation near-infrared fluorophore capable of maint

  2026.07.22